Scott A. Gangloff insider trades

Open-market stock purchases and sales by Scott A. Gangloff, Chief Technology Officer at Akero Therapeutics, Inc, from SEC Form 4 filings since Nov 9, 2016.

Recent trades

DateStockTradeValue
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)—
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)—
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$349K
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$2.2M
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$4M

Companies traded

  • AKRO Akero Therapeutics, Inc: 1 sale, last Dec 9, 2025
  • ONS Oncobiologics, Inc: 1 sale, last Dec 21, 2016

Get free alerts when Scott A. Gangloff files a new trade →